EBSCO Health Acquires Health Decision to Enhance Clinical Decision Support for Over 5.5 Million Users

VCBeat (WeChat Official Account: vcbeat) has learned that clinical information resources company EBSCO Health announced this morning its acquisition of Health Decision. This acquisition aims to develop tools to help clinicians and patients make more informed treatment decisions, and EBSCO Health will also gain access to Health Decision’s relevant technical resources. Further details of the acquisition have not yet been disclosed.

Health Decision had previously secured $2.2 million in financing. On January 1, 2016, Health Decision completed a $65,000 seed funding round, with the investing institutions undisclosed. On January 1, 2017, Health Decision completed a $1.55 million Series A funding round, with the investing institutions undisclosed.

Health Decision, founded in 2004, is a clinical software development company based in Wisconsin, USA. Its software products are developed with the involvement of clinicians and have been integrated into the standard clinical workflows within EHR systems. Serving over 5.5 million physicians and patients, the company has achieved exceptionally high user satisfaction.

Health Decision’s software products include software tools for assessing cardiovascular risk, detecting atrial fibrillation, and screening for lung cancer and breast cancer. The cardiovascular risk assessment tool calculates a patient’s 10-year risk of developing cardiovascular disease based on the 2013 ACC/AHA guidelines, evaluates the impact of statins and smoking on cardiovascular disease, and presents the results in data format. The Atrial Fibrillation detection tool incorporates the ACC/AHA guideline recommendations on risk-specific anticoagulation therapy, calculates the HAS-BLED score to assess bleeding risks at 1, 5, and 10 years, and displays the impact of anticoagulants on these risks. The breast cancer screening tool uses the BCSC Risk Calculator to determine a patient’s 10-year probability of developing breast cancer, presents the results graphically, and reduces the likelihood of overdiagnosis and false positives.

EBSCO Health is a provider of clinical decision support solutions and healthcare business intelligence for the medical industry. Its product portfolio includes medical e-books, medical databases, clinical decision support tools, and medical journals, enabling patients to access comprehensive information on clinical diagnosis and treatment through the EBSCO Health platform.

“Health Decision is an important decision support tool that can be seamlessly integrated into our clinical product suite, enhancing our existing offerings and improving the user experience,” said Betsy Jones, Senior Vice President of Product Management at EBSCO Health, in a statement.

EHR is a system designed to help physicians and patients identify suitable medical software. The EHR system comprises 83 experienced software consultants and integrates hundreds of medical software solutions. Within just ten minutes, it provides users with a free, impartial, and authoritative list of recommended software. Additionally, professional consultants assist users in making informed choices, helping them save both time and money. The medical software featured within the EHR system enjoys high industry credibility and has served over 600,000 users.